Key facts
- This page summarizes Eric Thomas Schmidt's Form 4 filing for Allogene Therapeutics, Inc. (ALLO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Mar 2023, 20:17.
Eric Thomas Schmidt - 22 Mar 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ALLO
- Reported as of
- 22 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Mar 2023, 20:17:56 UTC
- Prior SEC filing
- 16 Mar 2023
- Next SEC filing
- 30 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/Veer Bhavnagri, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eric Thomas Schmidt filed Form 4 for Allogene Therapeutics, Inc. (ALLO) on 24 Mar 2023.
Change
- Previous filing in this sequence was filed on 16 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALLO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +558,094
- Change %
- +183%
- Price
- $0.000000
- Shares after
- 862,439
- Date
- 22 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
ALLO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,152,595
- Date
- 22 Mar 2023
- Ownership
- See footnote
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALLO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +432,738
- Change %
- Price
- $0.000000
- Shares after
- 432,738
- Date
- 22 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 432,738
- Exercise price
- $5.04
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes 429,303 of performance RSUs which shall vest as follows: (1) 50% shall vest if the 30-day weighted average stock price is equal to or greater than $18 and (2) 50% shall vest upon the first regulatory approval of a product candidate. Notwithstanding the foregoing (1) any portion that vests upon the stock price threshold shall no longer vest and be terminated after three years from the grant date if such threshold has not been met in such three-year period, and (2) any portion that vests upon product candidate approval shall no longer vest and be terminated after five years from the grant date if such approval has not occurred in such five-year period.
Footnote F2
The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust
Footnote F3
25% of the shares subject to the stock option shall vest on March 13, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.